UBS AM’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-97,160
| Closed | -$17.5M | – | 2650 |
|
2017
Q3 | $17.5M | Sell |
97,160
-183,290
| -65% | -$33M | 0.02% | 760 |
|
2017
Q2 | $29.1M | Sell |
280,450
-32,118
| -10% | -$3.33M | 0.03% | 599 |
|
2017
Q1 | $24.5M | Sell |
312,568
-91,569
| -23% | -$7.19M | 0.03% | 648 |
|
2016
Q4 | $18.1M | Buy |
404,137
+11,291
| +3% | +$506K | 0.02% | 717 |
|
2016
Q3 | $21.9M | Sell |
392,846
-14,390
| -4% | -$804K | 0.02% | 649 |
|
2016
Q2 | $20.4M | Buy |
407,236
+29,658
| +8% | +$1.48M | 0.02% | 672 |
|
2016
Q1 | $17.3M | Buy |
377,578
+10,167
| +3% | +$467K | 0.02% | 708 |
|
2015
Q4 | $22.6M | Sell |
367,411
-53,206
| -13% | -$3.28M | 0.03% | 626 |
|
2015
Q3 | $23.4M | Sell |
420,617
-1,782
| -0.4% | -$99.2K | 0.03% | 633 |
|
2015
Q2 | $25.8M | Buy |
422,399
+93,599
| +28% | +$5.71M | 0.02% | 632 |
|
2015
Q1 | $19M | Buy |
328,800
+319,500
| +3,435% | +$18.4M | 0.02% | 723 |
|
2014
Q4 | $536K | Sell |
9,300
-66,300
| -88% | -$3.82M | ﹤0.01% | 1911 |
|
2014
Q3 | $2.16M | Buy |
+75,600
| New | +$2.16M | ﹤0.01% | 1279 |
|